Emmaues
- Address
- Liersesteenweg 435, 2800 Mechelen, Belgium
Oncology and Hematologic Malignancies
At Emmaues, cancer research is a major focus, with studies spanning non-small cell lung cancer, small cell lung cancer, breast cancer, colorectal cancer, and several lymphomas and leukemias. The trials are designed to test new treatment options, compare them with current standards, and improve outcomes for patients with advanced or hard-to-treat disease.
- Non-small cell lung cancer, small cell lung cancer, and lung cancer are central research areas
- Breast cancer, colorectal cancer, and neuroendocrine tumours are also represented
- Studies in CLL, SLL, DLBCL, and multiple myeloma explore better treatment effectiveness
Much of the work at this hospital-based research site is aimed at evaluating targeted therapies, immunotherapy combinations, and more effective approaches for patients whose cancers have progressed after earlier treatment.
Respiratory Medicine and Pulmonary Disease
Research in respiratory tract diseases is especially active, covering asthma, COPD, chronic cough, bronchiectasis, and pneumonia. These trials focus on improving symptom control, reducing flare-ups, and finding better long-term options for people living with chronic breathing disorders.
- Asthma studies include uncontrolled and type 2 inflammatory disease
- COPD trials aim to lower exacerbations and support better daily function
- Chronic cough, bronchiectasis, and pneumonia research addresses persistent respiratory symptoms and infection-related illness
The respiratory portfolio at Emmaues also includes work on immune-based therapies, reflecting a broader effort to improve both treatment effectiveness and quality of life.
Cardiovascular, Metabolic, and Kidney-Related Research
Trials in cardiovascular diseases and nutritional and metabolic diseases examine conditions such as atherosclerotic cardiovascular disease, elevated lipoprotein(a), hypertriglyceridemia, obesity, and weight management. There is also research involving chronic kidney disease and systemic inflammation, with the goal of reducing major heart events and improving metabolic health.
- Cardiovascular disease studies focus on preventing heart attack, stroke, and related complications
- Lipoprotein(a) and triglyceride research explores new ways to lower lipid-related risk
- Obesity and weight management trials assess treatments that support healthier body weight
These studies at the AZ Sint Maarten department in Mechelen aim to improve prevention and long-term control of cardiometabolic disease.
Immunology, Infectious Disease, and Vaccination Research
This site also contributes to research on virus diseases, bacterial infections, and immune system phenomena. Trials include studies of influenza, respiratory syncytial virus, human metapneumovirus, urinary tract infections, and COVID-19, along with vaccine studies in healthy adults and older populations.
- Influenza and RSV vaccine studies evaluate protection and immune response
- UTI research looks at prevention of E. coli-related infection
- COVID-19 and other respiratory infection studies assess treatment support and disease control
The research activity here reflects a strong interest in preventing infection, strengthening immune protection, and improving care for common community and seasonal illnesses.
Neurology and Symptom Management
Clinical trials in nervous system diseases at Emmaues include migraine and chronic cough-related symptom burden, with a broader emphasis on easing persistent symptoms that affect daily life. These studies aim to improve control of recurring neurological and airway-related complaints.
- Chronic migraine and episodic migraine are being studied to reduce attack frequency
- Refractory and unexplained chronic cough research targets troublesome long-term symptoms
- Trials focus on better symptom relief and improved patient well-being
By addressing conditions that can be disabling even when not life-threatening, this research supports more practical and patient-centered care.
Digestive, Liver, and Inflammation-Related Research
The site’s work in digestive system diseases includes studies of cirrhosis and other conditions linked to liver damage and fluid balance. Some trials also examine inflammation-related disease processes, reflecting interest in how chronic illness affects multiple organ systems.
- Cirrhosis of the liver is a key area of investigation
- Studies evaluate treatments intended to improve disease control and patient stability
- Immune system and inflammation research connects with broader internal medicine care
These studies add to the broader clinical research profile at the hospital/clinic, where complex chronic diseases are being studied across several specialties.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 15 therapeutic areas and 15 of 174 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 169 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 21 by active trials.
- 1Merck Sharp & Dohme LLC4active
lock +20 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Amgen Inc.8trials
lock +14 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Emmaues
lock Showing 1 of 77 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab | Merck Sharp & Dohme LLC | Phase III | Recruiting | Aug 2018 | — |
IMP list
lock Showing 1 of 174 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pembrolizumab | 8 | Unknown | 2018-03-21 | 2025-09-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
